Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Genmab
Eli Lilly and Company
H. Lee Moffitt Cancer Center and Research Institute
iOnctura
Merck Sharp & Dohme LLC
Eli Lilly and Company
Pfizer
City of Hope Medical Center
AstraZeneca
HonorHealth Research Institute
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Jonsson Comprehensive Cancer Center
University of Southern California
National Cancer Institute (NCI)
University of Vermont
Tesaro, Inc.
AbbVie
Memorial Sloan Kettering Cancer Center
Toray Industries, Inc
Dana-Farber Cancer Institute
Eli Lilly and Company
Daiichi Sankyo
University Hospital, Geneva
University College, London